BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10829038)

  • 1. Population-based molecular detection of hereditary nonpolyposis colorectal cancer.
    Salovaara R; Loukola A; Kristo P; Kääriäinen H; Ahtola H; Eskelinen M; Härkönen N; Julkunen R; Kangas E; Ojala S; Tulikoura J; Valkamo E; Järvinen H; Mecklin JP; Aaltonen LA; de la Chapelle A
    J Clin Oncol; 2000 Jun; 18(11):2193-200. PubMed ID: 10829038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer.
    Loukola A; Salovaara R; Kristo P; Moisio AL; Kääriäinen H; Ahtola H; Eskelinen M; Härkönen N; Julkunen R; Kangas E; Ojala S; Tulikoura J; Valkamo E; Järvinen H; Mecklin JP; de la Chapelle A; Aaltonen LA
    Am J Pathol; 1999 Dec; 155(6):1849-53. PubMed ID: 10595914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study.
    Percesepe A; Borghi F; Menigatti M; Losi L; Foroni M; Di Gregorio C; Rossi G; Pedroni M; Sala E; Vaccina F; Roncucci L; Benatti P; Viel A; Genuardi M; Marra G; Kristo P; Peltomäki P; Ponz de Leon M
    J Clin Oncol; 2001 Oct; 19(19):3944-50. PubMed ID: 11579115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing for hereditary nonpolyposis colorectal cancer.
    Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
    Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
    Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
    JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
    Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
    Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
    Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
    N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
    Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
    Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC).
    Loukola A; Eklin K; Laiho P; Salovaara R; Kristo P; Järvinen H; Mecklin JP; Launonen V; Aaltonen LA
    Cancer Res; 2001 Jun; 61(11):4545-9. PubMed ID: 11389088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
    Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
    Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.